You are on page 1of 9

AD-Times

2018-19

COMPANY NAME:
ABBOTT
Industry – Bird’s Eye View
• The pharmaceutical sector was valued
at US$ 33 billion in 2017

• The country’s pharmaceutical industry is


expected to expand at a CAGR of 22.4
per cent over 2015–20 to reach US$ 55
billion.

• India’s pharmaceutical exports stood at


US$ 17.27 billion in 2017-18 and are
expected to reach US$ 20 billion by
2020

• Indian drugs are exported to more than


200 countries in the world, with the US
as the key market
Abbott India Ltd. – Introduction
• Abbott India Ltd is one of India's fastest growing pharmaceutical companies
and part of Abbott's Global Pharmaceutical business in India.

• Headquartered in Mumbai, Abbott India Ltd, a publicly listed company and a


subsidiary of Abbott Laboratories, enjoys strong brand equity in multiple
therapeutic categories

• Global presence in over 130 countries


Abbott India Ltd. – Strategy/Vision
OUR PROMISE

• We believe that health is the key to fulfilling the promise of human potential.
Because at our healthiest, we’re capable of achieving anything.

• Caring is central to the work we do

• We believe that diverse perspectives combined with shared goals inspire new
ideas.

VALUES

• We commit to serve the highest standards of quality, excellence in personal


relationships, and behavior characterized by honesty, fairness and integrity.

• We value our diversity—that of our products, technologies, markets and people


Abbott India Ltd. – Product-lines
Product-line consists of four major categories- Pharmaceuticals (HUMIRA,
Digene, Brufen), Nutrition (Ensure, Prosure, EAS, Similac, Pidealyte),
Diagnostics (Core laboratory, Molecular, Point-of-care) , Medical Devices
(Vascular, Vision, Diabetic Care)
STRENGTHS WEAKNESSES

1. Collaboration with Syngene: established 1.Available only in certain countries


first nutrition research and development
2.Company is overly dependent upon
2. Abbott Molecular acquired exclusive mature products
license to develop a diagnostic test in US
3.Faces lot of litigation cases in
3.Strong employee force of 90,000 various countries about its products

OPPORTUNITIES THREATS

1. Broad-based medical innovation: 1. Increasing obsolesce of technology


technologies & businesses in health care
2. Competition from peers
2. Pioneering solutions that advance
health care
Abbott India Ltd. – Brand
Communication
Deliverables : Print communications, iconography, illustration, information design,
imagery research and image library
News
• Abbott Laboratories raised its full-year earnings forecast and topped estimates
for quarterly profit (Q2 2018), powered by demand for its glucose monitoring
device for diabetics and gains from its multibillion dollar acquisitions (JULY 18,
2018)
https://www.reuters.com/article/us-abbott-results/abbott-labs-raises-2018-earnings-forecast-shares-hit-record-high-idUSKBN1K81IU

• Integrated Investment Consultants LLC increased its position in shares of


Abbott Laboratories (NYSE:ABT) by 224.8% during the second quarter,
according to its most recent filing with the Securities & Exchange Commission
(Aug 12th, 2018)
https://www.fairfieldcurrent.com/2018/08/12/integrated-investment-consultants-llc-raises-position-in-abbott-laboratories-abt.html

• Abbott Labs shares lift 2.5% after Q2 profit (July 18, 2018)
https://www.marketwatch.com/story/abbott-labs-shares-lift-25-after-q2-profit-revenue-beats-2018-07-18

• American drug maker Abbott has quit Organisation of Pharmaceutical


Producers of India (OPPI) primarily due to vital differences on Intellectual
Property Right related issues. They are now in talks with Indian Pharmaceutical
Alliance (IPA) (July 7, 2018)
https://timesofindia.indiatimes.com/business/india-business/abbott-india-quits-mnc-lobby-ties-up-with-ipa/articleshow/65157139.cms
Summer Intern(2017) Interaction
• Number of shortlists: 150 students for Group Discussion

• Shortlist criteria: None

• Selection Process: GD round followed by 2 rounds of interview

• Number of shortlist from GD to PI: 25 to 30 got shortlisted from GD


round

• Typical PI questions: Questions were based on candidate’s work


experience and testing analytics

• Type of summer project: Strategy and Analytics

You might also like